GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Spectral Medical Inc (OTCPK:EDTXF) » Definitions » EV-to-EBIT

EDTXF (Spectral Medical) EV-to-EBIT : -6.51 (As of Dec. 14, 2024)


View and export this data going back to . Start your Free Trial

What is Spectral Medical EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Spectral Medical's Enterprise Value is $107.34 Mil. Spectral Medical's EBIT for the trailing twelve months (TTM) ended in Sep. 2024 was $-16.50 Mil. Therefore, Spectral Medical's EV-to-EBIT for today is -6.51.

The historical rank and industry rank for Spectral Medical's EV-to-EBIT or its related term are showing as below:

EDTXF' s EV-to-EBIT Range Over the Past 10 Years
Min: -57.7   Med: -14.58   Max: -2.95
Current: -6.51

During the past 13 years, the highest EV-to-EBIT of Spectral Medical was -2.95. The lowest was -57.70. And the median was -14.58.

EDTXF's EV-to-EBIT is ranked worse than
100% of 104 companies
in the Medical Diagnostics & Research industry
Industry Median: 21.155 vs EDTXF: -6.51

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Spectral Medical's Enterprise Value for the quarter that ended in Sep. 2024 was $132.87 Mil. Spectral Medical's EBIT for the trailing twelve months (TTM) ended in Sep. 2024 was $-16.50 Mil. Spectral Medical's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2024 was -12.42%.


Spectral Medical EV-to-EBIT Historical Data

The historical data trend for Spectral Medical's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Spectral Medical EV-to-EBIT Chart

Spectral Medical Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only -33.57 -10.01 -7.59 -13.25 -8.75

Spectral Medical Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -11.02 -8.75 -8.18 -8.28 -8.07

Competitive Comparison of Spectral Medical's EV-to-EBIT

For the Diagnostics & Research subindustry, Spectral Medical's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Spectral Medical's EV-to-EBIT Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Spectral Medical's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Spectral Medical's EV-to-EBIT falls into.



Spectral Medical EV-to-EBIT Calculation

Spectral Medical's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=107.344/-16.496
=-6.51

Spectral Medical's current Enterprise Value is $107.34 Mil.
Spectral Medical's EBIT for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-16.50 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Spectral Medical  (OTCPK:EDTXF) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Spectral Medical's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2024 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Sep. 2024 ) =EBIT / Enterprise Value (Q: Sep. 2024 )
=-16.496/132.866187
=-12.42 %

Spectral Medical's Enterprise Value for the quarter that ended in Sep. 2024 was $132.87 Mil.
Spectral Medical's EBIT for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-16.50 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Spectral Medical EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Spectral Medical's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Spectral Medical Business Description

Traded in Other Exchanges
Address
135 The West Mall, Unit 2, Finance, Toronto, ON, CAN, M9C 1C2
Spectral Medical Inc is focused on the development and commercialization of a treatment for septic shock utilizing its endotoxin activity assay (EAA) diagnostic and the Toraymyxin therapeutic. The company also manufactures and sells proprietary reagents. The product line of the company consists of proprietary biochemical, EAA, and instrumentation.